HomeSKYE • NASDAQ
add
Skye Bioscience Inc
Previous close
$1.71
Day range
$1.52 - $1.75
Year range
$1.14 - $17.65
Market cap
50.55M USD
Avg Volume
1.11M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 10.67M | 161.02% |
Net income | -9.75M | -120.51% |
Net profit margin | — | — |
Earnings per share | -0.29 | — |
EBITDA | -10.49M | -158.53% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 68.42M | 5,345.15% |
Total assets | 72.76M | 509.39% |
Total liabilities | 4.61M | -67.23% |
Total equity | 68.15M | — |
Shares outstanding | 30.97M | — |
Price to book | 0.78 | — |
Return on assets | -34.56% | — |
Return on capital | -36.88% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -9.75M | -120.51% |
Cash from operations | -8.17M | -112.58% |
Cash from investing | 90.41K | 1,388.44% |
Cash from financing | 5.62K | 124.80% |
Net change in cash | -8.08M | -108.47% |
Free cash flow | 4.15M | 277.20% |
About
Founded
2011
Website
Employees
16
